Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer.
Nat Commun. 2023 Sep 13;14(1):5631. doi: 10.1038/s41467-023-41352-0.
Nat Commun. 2023.
PMID: 37704621
Free PMC article.
Cell-Intrinsic CD38 Expression Sustains Exhausted CD8+ T Cells by Regulating Their Survival and Metabolism during Chronic Viral Infection.
DeRogatis JM, Neubert EN, Viramontes KM, Henriquez ML, Nicholas DA, Tinoco R.
DeRogatis JM, et al.
J Virol. 2023 Apr 27;97(4):e0022523. doi: 10.1128/jvi.00225-23. Epub 2023 Apr 11.
J Virol. 2023.
PMID: 37039663
Free PMC article.
Item in Clipboard
PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
Viramontes KM, Neubert EN, DeRogatis JM, Tinoco R.
Viramontes KM, et al.
Front Immunol. 2022 Jun 14;13:869768. doi: 10.3389/fimmu.2022.869768. eCollection 2022.
Front Immunol. 2022.
PMID: 35774790
Free PMC article.
Item in Clipboard
The cure from within? a review of the microbiome and diet in melanoma.
Kumar P, Brazel D, DeRogatis J, Valerin JBG, Whiteson K, Chow WA, Tinoco R, Moyers JT.
Kumar P, et al.
Cancer Metastasis Rev. 2022 Jun;41(2):261-280. doi: 10.1007/s10555-022-10029-3. Epub 2022 Apr 27.
Cancer Metastasis Rev. 2022.
PMID: 35474500
Free PMC article.
Review.
Item in Clipboard
Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1-Resistant Melanoma.
DeRogatis JM, Viramontes KM, Neubert EN, Henriquez ML, Guerrero-Juarez CF, Tinoco R.
DeRogatis JM, et al.
Cancer Immunol Res. 2022 May 3;10(5):612-625. doi: 10.1158/2326-6066.CIR-21-0690.
Cancer Immunol Res. 2022.
PMID: 35303066
Free PMC article.
Item in Clipboard
PSGL-1 Is a T Cell Intrinsic Inhibitor That Regulates Effector and Memory Differentiation and Responses During Viral Infection.
Tinoco R, Neubert EN, Stairiker CJ, Henriquez ML, Bradley LM.
Tinoco R, et al.
Front Immunol. 2021 Jul 13;12:677824. doi: 10.3389/fimmu.2021.677824. eCollection 2021.
Front Immunol. 2021.
PMID: 34326837
Free PMC article.
Item in Clipboard
PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy.
DeRogatis JM, Viramontes KM, Neubert EN, Tinoco R.
DeRogatis JM, et al.
Front Immunol. 2021 Feb 23;12:636238. doi: 10.3389/fimmu.2021.636238. eCollection 2021.
Front Immunol. 2021.
PMID: 33708224
Free PMC article.
Review.
Item in Clipboard
Cite
Cite